[Difficulties in managing Graves' disease in children: about a case]

Nassiba Elouarradi1, Ghizlane El Mghari1, Nawal El Ansari1

  • 1Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, CHU Mohamed VI, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Maroc.

Insights

Graves disease management in children remains challenging. This case highlights treatment difficulties, including side effects from antithyroid drugs and the need for alternative therapies like radioactive iodine therapy.

Area of Science:

  • Pediatric Endocrinology
  • Thyroidology
  • Internal Medicine

Background:

  • Graves' disease is the leading cause of hyperthyroidism in children, yet its optimal management, including treatment duration and alternative therapies, is debated.
  • Effective management strategies for pediatric Graves' disease are crucial due to potential long-term health implications.

Observation:

  • A case of an 11-year-old female presenting with symptoms of hyperthyroidism, including weight loss, diarrhea, and cervical swelling.
  • Diagnosis of Graves' disease was confirmed through clinical and paraclinical evaluations.

Findings:

  • Medical treatment with carbimazole was initiated, but the patient developed thrombocytopenia, necessitating cautious administration.
  • After four years without remission, radioactive iodine therapy was indicated as an alternative treatment.
  • Synthetic antithyroid drugs, while common, can have adverse effects, as demonstrated in this case.

Implications:

  • This case underscores the complexities in managing pediatric Graves' disease, particularly concerning medication side effects and treatment resistance.
  • The findings suggest that alternative therapies such as radioactive iodine therapy should be considered when medical management fails or causes significant adverse events.
  • Further research into optimizing treatment duration and indications for alternative therapies in pediatric Graves' disease is warranted.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...